2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Cystitis, Interstitial
1
Interventions
Specimen Handling
662
pembrolizumab
612
Magnetic Resonance Spectroscopy
565
Carboplatin
451
Cisplatin
400
Cyclophosphamide
399
Biopsy
385
Nivolumab
329
Paclitaxel
324
Gemcitabine
317
Radiotherapy
302
Bevacizumab
250
Dexamethasone
223
fludarabine
217
Docetaxel
203
durvalumab
196
Oxaliplatin
189
venetoclax
188
atezolizumab
188
Fluorouracil
178
Rituximab
177
Pemetrexed
174
Capecitabine
172
Radiation
171
Doxorubicin
168
Radiosurgery
161
Ipilimumab
149
Etoposide
142
Leucovorin
141
Lenalidomide
140
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
chondroitin sulfate, sodium hyaluronate drug combination
×
90 days
×
Clear all
NCT07495072
2026-03-27
PRO-GAG
BLAD-HYA Group
Phase NA
Recruiting
56 enrolled